Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Invested Capital: 2012-2025

Historic Invested Capital for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to $374.1 million.

  • CorMedix's Invested Capital rose 537.23% to $374.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.1 million, marking a year-over-year increase of 537.23%. This contributed to the annual value of $84.7 million for FY2024, which is N/A change from last year.
  • CorMedix's Invested Capital amounted to $374.1 million in Q3 2025, which was up 69.57% from $220.6 million recorded in Q2 2025.
  • CorMedix's Invested Capital's 5-year high stood at $374.1 million during Q3 2025, with a 5-year trough of $46.2 million in Q2 2024.
  • Its 3-year average for Invested Capital is $114.3 million, with a median of $71.0 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first declined by 29.43% in 2024, then surged by 537.23% in 2025.
  • CorMedix's Invested Capital (Quarterly) stood at $62.8 million in 2021, then declined by 12.32% to $55.1 million in 2022, then soared by 47.75% to $83.2 million in 2023, then decreased by 29.43% to $84.7 million in 2024, then skyrocketed by 537.23% to $374.1 million in 2025.
  • Its Invested Capital stands at $374.1 million for Q3 2025, versus $220.6 million for Q2 2025 and $114.9 million for Q1 2025.